Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Operating Expenses (2018 - 2023)

Historic Operating Expenses for ImmunoTech (AIM) over the last 8 years, with Q4 2023 value amounting to $14.1 million.

  • ImmunoTech's Operating Expenses changed N/A to $14.1 million in Q4 2023 from the same period last year, while for Sep 2024 it was $14.1 million, marking a year-over-year increase of 2134.72%. This contributed to the annual value of $19.9 million for FY2024, which is 3791.02% down from last year.
  • ImmunoTech's Operating Expenses amounted to $14.1 million in Q4 2023.
  • In the past 5 years, ImmunoTech's Operating Expenses ranged from a high of $14.1 million in Q4 2023 and a low of $3.4 million during Q1 2020